The PE Ratio as of December 2024 (TTM) for Avadel Pharmaceuticals plc (AVDL) is -13.52

According to Avadel Pharmaceuticals plc’s latest financial reports and current stock price. The company's current PE Ratio is -13.52. This represents a change of -68.28% compared to the average of -42.63 of the last 4 quarters.

Avadel Pharmaceuticals plc (AVDL) Historical PE Ratio (quarterly & annually)

How has AVDL PE Ratio performed in the past?

The mean historical PE Ratio of Avadel Pharmaceuticals plc over the last ten years is 2.40. The current -13.52 PE Ratio has changed -56471.96% with respect to the historical average. Over the past ten years (40 quarters), AVDL's PE Ratio was at its highest in in the December 2016 quarter at 22.64. The PE Ratio was at its lowest in in the September 2024 quarter at -120.33.

Avadel Pharmaceuticals plc (AVDL) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Avadel Pharmaceuticals plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Avadel Pharmaceuticals plc (AVDL) Average PE Ratio

How has AVDL PE Ratio performed in the past?

The current PE Ratio of Avadel Pharmaceuticals plc (AVDL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Avadel Pharmaceuticals plc (AVDL) PE Ratio vs. Peers

How is AVDL’s PE Ratio compared to its peers?

Avadel Pharmaceuticals plc’s PE Ratio is less than Neurocrine Biosciences, Inc. (35.89), less than Deciphera Pharmaceuticals, Inc. (-11.74), less than Ironwood Pharmaceuticals, Inc. (29.34), less than Alkermes plc (14.46), greater than Intra-Cellular Therapies, Inc. (-102.87), less than Dynavax Technologies Corporation (82.16), less than Journey Medical Corporation (-5.10), less than Evoke Pharma, Inc. (-1.13), less than Jupiter Wellness, Inc. (-1.00), less than Aquestive Therapeutics, Inc. (-9.29), less than Eagle Pharmaceuticals, Inc. (0.20), greater than ANI Pharmaceuticals, Inc. (-148.34), less than Agile Therapeutics, Inc. (-0.65), less than Assertio Holdings, Inc. (-1.18), less than Amneal Pharmaceuticals, Inc. (-13.08), less than AcelRx Pharmaceuticals, Inc. (-1.03), less than Lifecore Biomedical, Inc. (33.18),

Build a custom stock screener for Avadel Pharmaceuticals plc (AVDL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Avadel Pharmaceuticals plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Avadel Pharmaceuticals plc (AVDL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Avadel Pharmaceuticals plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.